
Myriad Genetics Inc Share Price
NASDAQ: MYGNHealthcare
Live Myriad Genetics Inc Share Price Chart
O H L
Myriad Genetics Inc Performance Overview
Days Range
▼
$4.07Low
$4.28High
Markets Today
| Previous Close | $4.08 |
|---|---|
| Open | $4.08 |
| Volume | 1,849,031 |
| Day's Range | $4.07 - $4.28 |
| 52W Range | $2.74 - $8.59 |
| Market Cap | $401.73 M |
Historical Performance
| 1M Returns | +6.96 |
|---|---|
| 3M Returns | -34.23 |
| 6M Returns | -20.04 |
| 1Y Returns | -48.77 |
| 5Y Returns | -86.93 |
| 10Y Returns | -78.51 |
Myriad Genetics Inc Fundamentals
| Market Cap | $401.73 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $824.50 M |
| ROE TTM | -0.68 |
| EPS TTM | $-1.20 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.32 |
| EBITDA | $-14.10 M |
| Profit Margin | -44.38 |
| Market Cap | $401.73 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $824.50 M |
| ROE TTM | -0.68 |
| EPS TTM | $-1.20 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.32 |
| EBITDA | $-14.10 M |
| Profit Margin | -44.38 |
Myriad Genetics Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $195.90 M | $213.10 M | $205.70 M | $209.80 M | $200.40 M | $190.70 M |
| Gross Profit + | $134.20 M | $151.80 M | $143.80 M | $146.80 M | $137.60 M | $127.00 M |
| Operating Income | -$29.00 M | -$329.20 M | -$23.30 M | -$5.70 M | -$30.70 M | -$38.90 M |
| EBITDA | -$14.60 M | $1.60 M | -$10.70 M | $9.60 M | -$12.80 M | -$26.40 M |
| Interest Expense | -$800.00 K | -$1.50 M | -$3.80 M | -$4.40 M | -$4.10 M | -$4.10 M |
| Depreciation | $14.40 M | $330.80 M | $12.60 M | $15.30 M | $17.90 M | $12.50 M |
| Income Before Tax | -$29.40 M | -$330.60 M | -$26.20 M | -$8.90 M | -$34.10 M | -$42.60 M |
| Income Tax Expense | -$29.30 M | -$100.00 K | $1.20 M | -$1.00 M | $0 | $600.00 K |
| Net Income + | -$100.00 K | -$330.50 M | -$27.40 M | -$7.90 M | -$34.10 M | -$43.20 M |
| Net Profit Margin | -0.05% | -155.09% | -13.32% | -3.77% | -17.02% | -22.65% |
Myriad Genetics Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $900.00 K | $900.00 K | $900.00 K | $900.00 K | $900.00 K | $1.00 M |
| Reserve & Surplus | -$757.50 M | -$1.09 B | -$1.11 B | -$1.12 B | -$1.16 B | -$1.20 B |
| Non-Current Liabilities | $150.10 M | $89.30 M | $207.30 M | $204.80 M | $206.10 M | $204.30 M |
| Current Liabilities | $151.10 M | $199.90 M | $148.00 M | $133.80 M | $130.20 M | $130.70 M |
| Total Liabilities | $301.20 M | $289.20 M | $355.30 M | $338.60 M | $336.30 M | $335.00 M |
| Fixed Assets | $371.50 M | $283.10 M | $274.50 M | $267.40 M | $257.20 M | $247.90 M |
| Current Assets | $287.20 M | $284.30 M | $344.80 M | $332.60 M | $312.80 M | $289.00 M |
| Total Assets | $1.01 B | $677.30 M | $728.10 M | $706.60 M | $673.70 M | $638.90 M |
Myriad Genetics Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$100.00 K | -$330.50 M | -$27.40 M | -$7.90 M | -$34.10 M | -$43.20 M |
| Operating Cash Flow | -$16.30 M | -$13.60 M | $21.10 M | $10.60 M | -$15.70 M | -$8.30 M |
| Investing Cash Flow | -$8.30 M | -$6.90 M | -$6.20 M | -$6.00 M | -$6.50 M | -$3.20 M |
| Financing Cash Flow | $13.60 M | $2.60 M | $56.20 M | -$8.20 M | -$3.00 M | $2.20 M |
| Change in Cash | -$10.90 M | -$17.30 M | $71.10 M | -$3.50 M | -$25.30 M | -$9.20 M |
Myriad Genetics Inc Return Calculator
The Myriad Genetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,241
Invested Amount$10,000
Est. Returns$-8,759
About Myriad Genetics Inc
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Popular Stocks
FAQs
What is the share price of Myriad Genetics Inc today?
Myriad Genetics Inc (MYGN) share price as of October 15, 2026 is $3.94. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Myriad Genetics Inc?
Yes, Indian Investors can invest in the Myriad Genetics Inc (MYGN) Share by opening an international trading account with Angel One.
How can I purchase Myriad Genetics Inc shares in India?
Purchasing Myriad Genetics Inc (MYGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Myriad Genetics Inc (MYGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Myriad Genetics Inc?
Yes, you can purchase fractional shares of Myriad Genetics Inc (MYGN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Myriad Genetics Inc?
The market capitalization of Myriad Genetics Inc on October 15, 2026, is $401.73 M.
In which sector Myriad Genetics Inc belongs?
Myriad Genetics Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Myriad Genetics Inc stocks?
In order to invest in Myriad Genetics Inc (MYGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
